Author:
Adhikari Arjab,Sapkota Supriya,Gogia Sopiko,KC Ojbindra
Reference18 articles.
1. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†;Escudier;Ann. Oncol.,2019
2. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Engl. J. Med.,2015
3. Nivolumab plus Ipilimumab versus sunitinib in advanced renal-cell carcinoma;Motzer;N. Engl. J. Med.,2018
4. Young J.L. Jr, Roffers S.D., Ries L.A.G., Fritz A.G., Hurlbut A.A. SEER Summary Staging Manual - 2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
5. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer;Yagoda;Cancer,1993